Clinical Trial Update: Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase IIa randomized study of QGC001 versus placebo in essential hypertension, sponsored by Quantum Genomics SA, whose tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• QGC001

Snippet

Sponsor: Quantum Genomics SA | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED